SHL Medical
Stephen Oesterle is a seasoned health care consultant with extensive experience serving on the boards of various public and privately held companies, including Baxter International Inc. as a Board Director and Chair of the Quality & Compliance Committee. Oesterle holds additional board roles at Peijia Medical, Paragon 28, CeramTec, SHL Medical, and Alcyone Therapeutics, contributing to committees focused on governance, compensation, and quality. With a strong educational background, including a B.A. from Harvard University, an MD from Yale University, and post-doctoral fellowships in Internal Medicine and Interventional Cardiology, Oesterle also serves as a Corporate Advisor for Temasek and an Industrial Advisor for EQT Partners, further enhancing expertise in active ownership strategies and venture capital.
This person is not in any teams
This person is not in any offices
SHL Medical
8 followers
SHL Medical is a world-leading solutions provider of advanced drug delivery systems, such as autoinjectors. Driven by our company purpose – Enabling Patients’ Independence, we partner with leading pharma and biotech companies to pioneer the development of patient-centric solutions that support the enhancement of patients’ quality of life through self-injection systems as well as digital healthcare solutions. With over 5,000 employees located across our Switzerland, USA, Sweden and Taiwan offices, we rely on our comprehensive in-house manufacturing capabilities to provide end-to-end services, from design, development to final assembly, labeling, and packaging.